Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions
Neurological disorders are the biggest concern globally. Out of ~36 million human immunodeficiency virus (HIV) positive people, about 30%–60% exhibit neurological disorders, including dementia and Alzheimer’s disease (AD) like pathology. In AD or AD like neurological disorders, the pathogenesis is m...
Main Authors: | Sneham Tiwari, Venkata Subba Rao Atluri, Adriana Yndart Arias, Rahul Dev Jayant, Ajeet Kaushik, Jonathan Geiger, Madhavan N. Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2018.00291/full |
Similar Items
-
Inhibition of Amyloid-Beta Production, Associated Neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology in Alzheimer’s Disease in vitro Model
by: Venkata Subba Rao Atluri, et al.
Published: (2020-01-01) -
Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
by: Tapan Behl, et al.
Published: (2020-12-01) -
Withaferin-A Can Be Used to Modulate the Keratin Network of Intermediate Filaments in Human Epidermal Keratinocytes
by: Michael C. Keeling, et al.
Published: (2020-06-01) -
HIV-1 Tat and cocaine impact mitochondrial epigenetics: effects on DNA methylation
by: Mayur Doke, et al.
Published: (2021-09-01) -
Withaferin A inhibits osteosarcoma cells through inactivation of Notch-1 signalling
by: Yang Chen, et al.
Published: (2014-08-01)